SELLERS ROBERT W.A. 4
4 · Edwards Lifesciences Corp · Filed Feb 12, 2024
Insider Transaction Report
Form 4
SELLERS ROBERT W.A.
VP, Corporate Controller
Transactions
- Exercise/Conversion
Common Stock
2024-02-12$36.75/sh+12,210$448,718→ 25,297.184 total - Sale
Common Stock
2024-02-12$87.00/sh−12,210$1,062,270→ 13,087.184 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2024-02-12−12,210→ 0 totalExercise: $36.75From: 2018-05-11Exp: 2024-05-10→ Common Stock (12,210 underlying)
Holdings
- 20,409(indirect: By Trust)
Common Stock